Pfizer to Launch a Global Cost-cutting Program If COVID-19 Vaccine Keeps Underperforming
The pharmaceutical giant Pfizer has announced that it will scale back its investment if the demand for COVID vaccine remains low this year. Pfizer also announced it to initiate a cost-cutting program if it’s COVID-19 and antiviral medications continue to underperform due to low demand. The company also said that this year’s fall demand is […]